Fieldpoint Private Securities’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$30K Sell
1,521
-3
-0.2% -$61 0.01% 565
2022
Q1
$42K Hold
1,524
0.01% 636
2021
Q4
$63K Hold
1,524
0.01% 544
2021
Q3
$71K Hold
1,524
0.02% 495
2021
Q2
$67K Sell
1,524
-19
-1% -$812 0.01% 512
2021
Q1
$83K Sell
1,543
-450
-23% -$25.9K 0.02% 432
2020
Q4
$98K Buy
+1,993
New +$92.4K 0.02% 408
2020
Q1
Sell
-5,972
Closed -$166K 547
2019
Q4
$166K Buy
5,972
+3,668
+159% +$94.9K 0.05% 286
2019
Q3
$55K Sell
2,304
-198
-8% -$5.27K 0.02% 377
2019
Q2
$71K Buy
+2,502
New +$62.5K 0.02% 379

Other funds holding VCYT

Fieldpoint Private Securities's VCYT Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Veracyte (VCYT) stake by 0.2% in Q2 2022, selling an estimated $61 and leaving 1,521 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #565.

Fieldpoint Private Securities first reported a position in VCYT in Q2 2019 and has held it in 10 quarters since. The position peaked at $166K in Q4 2019. 193 funds tracked by Wall St. Rank hold VCYT as of Q2 2022.

  • Fieldpoint Private Securities held 1,521 shares of Veracyte worth $30K as of Q2 2022.
  • Fieldpoint Private Securities sold 3 Veracyte shares in Q2 2022, an estimated $61.
  • Veracyte made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #565 holding.
  • Fieldpoint Private Securities first reported a position in Veracyte in Q2 2019 and has held it in 10 quarters since.
  • Fieldpoint Private Securities's Veracyte position peaked at $166K in Q4 2019.
  • 193 funds tracked by Wall St. Rank held Veracyte as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.